97 related articles for article (PubMed ID: 29518319)
1. Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents.
Hao M; Hou S; Xue L; Yuan H; Zhu L; Wang C; Wang B; Tang C; Zhang C
J Med Chem; 2018 Apr; 61(7):3059-3075. PubMed ID: 29518319
[TBL] [Abstract][Full Text] [Related]
2. Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.
Kang ZS; Wang C; Han XL; Wang B; Yuan HL; Hou SY; Hao MX; Du JJ; Li YY; Zhou AW; Zhang C
Eur J Med Chem; 2018 Sep; 157():1174-1191. PubMed ID: 30193216
[TBL] [Abstract][Full Text] [Related]
3. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Shen W; Xue J; Zhao Z; Zhang C
Eur J Med Chem; 2013 Nov; 69():768-78. PubMed ID: 24099996
[TBL] [Abstract][Full Text] [Related]
4. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
Ge Z; Hao M; Xu M; Su Z; Kang Z; Xue L; Zhang C
Eur J Med Chem; 2016 Jan; 107():48-62. PubMed ID: 26562542
[TBL] [Abstract][Full Text] [Related]
5. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling.
Zheng W; Duan B; Zhang Q; Ouyang L; Peng W; Qian F; Wang Y; Huang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30314996
[No Abstract] [Full Text] [Related]
8. Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.
Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
Eur J Med Chem; 2019 Feb; 163():787-803. PubMed ID: 30579121
[TBL] [Abstract][Full Text] [Related]
9. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of nonsecosteroidal vitamin D
Wang B; Hao M; Zhang C
Bioorg Med Chem Lett; 2017 Mar; 27(6):1428-1436. PubMed ID: 28216405
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton.
Wang C; Wang B; Xue L; Kang Z; Hou S; Du J; Zhang C
J Med Chem; 2018 Dec; 61(23):10573-10587. PubMed ID: 30350999
[TBL] [Abstract][Full Text] [Related]
12. Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton.
Misawa T; Yorioka M; Demizu Y; Noguchi-Yachide T; Ohoka N; Kurashima-Kinoshita M; Motoyoshi H; Nojiri H; Kittaka A; Makishima M; Naito M; Kurihara M
Bioorg Med Chem Lett; 2015 Nov; 25(22):5362-6. PubMed ID: 26432035
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.
Kumagai T; O'Kelly J; Said JW; Koeffler HP
J Natl Cancer Inst; 2003 Jun; 95(12):896-905. PubMed ID: 12813173
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.
Ishikawa T; Seto M; Banno H; Kawakita Y; Oorui M; Taniguchi T; Ohta Y; Tamura T; Nakayama A; Miki H; Kamiguchi H; Tanaka T; Habuka N; Sogabe S; Yano J; Aertgeerts K; Kamiyama K
J Med Chem; 2011 Dec; 54(23):8030-50. PubMed ID: 22003817
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
16. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
Gasparotto V; Castagliuolo I; Ferlin MG
J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
Brard L; Lange TS; Robison K; Kim KK; Ara T; McCallum MM; Arnold LA; Moore RG; Singh RK
Gynecol Oncol; 2011 Nov; 123(2):370-8. PubMed ID: 21803404
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
Berkovich L; Ben-Shabat S; Sintov AC
Anticancer Drugs; 2010 Jul; 21(6):609-18. PubMed ID: 20335794
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3-substituted-4-(4-methylthio phenyl)-1H-pyrrole derivatives as potential anticancer agents.
Lan L; Qin W; Zhan X; Liu Z; Mao Z
Anticancer Agents Med Chem; 2014; 14(7):994-1002. PubMed ID: 24372525
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
Valrance ME; Brunet AH; Welsh J
Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
